Site-Specific Association with Host and Viral Chromatin by Kaposi's Sarcoma-Associated Herpesvirus LANA and Its Reversal during Lytic Reactivation
暂无分享,去创建一个
[1] J. Weissman,et al. KSHV 2.0: A Comprehensive Annotation of the Kaposi's Sarcoma-Associated Herpesvirus Genome Using Next-Generation Sequencing Reveals Novel Genomic and Functional Features , 2014, PLoS pathogens.
[2] C. Tepper,et al. Biphasic Euchromatin-to-Heterochromatin Transition on the KSHV Genome Following De Novo Infection , 2013, PLoS pathogens.
[3] S. Verma,et al. Comprehensive Analysis of LANA Interacting Proteins Essential for Viral Genome Tethering and Persistence , 2013, PloS one.
[4] C. Boshoff,et al. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming. , 2013, Trends in cell biology.
[5] J. Lieb,et al. The Open Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus , 2013, Journal of Virology.
[6] Graziano Pesole,et al. PscanChIP: finding over-represented transcription factor-binding site motifs and their correlations in sequences from ChIP-Seq experiments , 2013, Nucleic Acids Res..
[7] Hiroshi Kimura,et al. Histone modifications for human epigenome analysis , 2013, Journal of Human Genetics.
[8] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[9] D. Ganem,et al. A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. , 2013, Cell host & microbe.
[10] D. Ganem,et al. Kaposi's sarcoma‐derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line , 2013, International journal of cancer.
[11] H. Kung,et al. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latency-Associated Nuclear Antigen Regulates the KSHV Epigenome by Association with the Histone Demethylase KDM3A , 2013, Journal of Virology.
[12] E. Robertson,et al. H2AX Phosphorylation Is Important for LANA-Mediated Kaposi's Sarcoma-Associated Herpesvirus Episome Persistence , 2013, Journal of Virology.
[13] David G Hendrickson,et al. Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.
[14] Mary Goldman,et al. The UCSC Genome Browser database: extensions and updates 2013 , 2012, Nucleic Acids Res..
[15] Jae U. Jung,et al. Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor. , 2012, Cancer research.
[16] John T. Lis,et al. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans , 2012, Nature Reviews Genetics.
[17] T. Bailey,et al. Inferring direct DNA binding from ChIP-seq , 2012, Nucleic acids research.
[18] R. Davuluri,et al. Identification of Host-Chromosome Binding Sites and Candidate Gene Targets for Kaposi's Sarcoma-Associated Herpesvirus LANA , 2012, Journal of Virology.
[19] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[20] C. Tepper,et al. Protein Arginine Methyltransferase 1-directed Methylation of Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen* , 2011, The Journal of Biological Chemistry.
[21] L. Aaltonen,et al. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. , 2011, Cell host & microbe.
[22] P. Desai,et al. KSHV regulation of fibulin-2 in Kaposi's sarcoma: implications for tumorigenesis. , 2011, The American journal of pathology.
[23] D. Schübeler,et al. Determinants and dynamics of genome accessibility , 2011, Nature Reviews Genetics.
[24] D. Ganem,et al. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. , 2011, Journal of virological methods.
[25] L. Su,et al. Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Down-Regulates IL-22R1 Expression through a Cis-Acting Element within the Promoter Region , 2011, PloS one.
[26] Philip Machanick,et al. MEME-ChIP: motif analysis of large DNA datasets , 2011, Bioinform..
[27] S. Cole,et al. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy , 2011, AIDS.
[28] Tao Ye,et al. seqMINER: an integrated ChIP-seq data interpretation platform , 2010, Nucleic acids research.
[29] Henriette O'Geen,et al. Genome-wide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes , 2010, BMC Genomics.
[30] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[31] P. Laird,et al. Epigenetic Analysis of KSHV Latent and Lytic Genomes , 2010, PLoS pathogens.
[32] T. Günther,et al. The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes , 2010, PLoS pathogens.
[33] S. Salzberg,et al. Transcript assembly and abundance estimation from RNA-Seq reveals thousands of new transcripts and switching among isoforms , 2010, Nature Biotechnology.
[34] M. Roupelieva,et al. Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex. , 2010, The Journal of general virology.
[35] D. Ganem. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. , 2010, The Journal of clinical investigation.
[36] S. Tojkander,et al. Nucleophosmin Phosphorylation by v-Cyclin-CDK6 Controls KSHV Latency , 2010, PLoS pathogens.
[37] Clifford A. Meyer,et al. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. , 2009, Genome research.
[38] C. Rossetto,et al. Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 K-bZIP Modulates Latency-Associated Nuclear Protein-Mediated Suppression of Lytic Origin-Dependent DNA Synthesis , 2009, Journal of Virology.
[39] Mikael Bodén,et al. MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..
[40] S. Verma,et al. Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their Proliferation , 2009, Journal of Virology.
[41] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[42] N. Barkai,et al. Two strategies for gene regulation by promoter nucleosomes. , 2008, Genome research.
[43] R. Morse. Transcription factor access to promoter elements , 2007, Journal of cellular biochemistry.
[44] Nathan H. Lents,et al. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. , 2007, Molecular cell.
[45] William Stafford Noble,et al. Quantifying similarity between motifs , 2007, Genome Biology.
[46] A. Krithivas,et al. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA , 2006, Proceedings of the National Academy of Sciences.
[47] Y. Takebe,et al. Ets-1-dependent Expression of Vascular Endothelial Growth Factor Receptors Is Activated by Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus through Interaction with Daxx* , 2006, Journal of Biological Chemistry.
[48] P. Lieberman,et al. Acetylation of the Latency-Associated Nuclear Antigen Regulates Repression of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription , 2006, Journal of Virology.
[49] S. Verma,et al. Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Modulates K1 Expression through Its cis-Acting Elements within the Terminal Repeats , 2006, Journal of Virology.
[50] K. Luger,et al. The Nucleosomal Surface as a Docking Station for Kaposi's Sarcoma Herpesvirus LANA , 2006, Science.
[51] Terrence S. Furey,et al. The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..
[52] A. Moses,et al. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. , 2005, Cancer research.
[53] E. Robertson,et al. Kaposi's Sarcoma-Associated Herpesvirus Reactivation Is Regulated by Interaction of Latency-Associated Nuclear Antigen with Recombination Signal Sequence-Binding Protein Jκ, the Major Downstream Effector of the Notch Signaling Pathway , 2005, Journal of Virology.
[54] Jianhong Hu,et al. Characterization of the Minimal Replicator of Kaposi's Sarcoma-Associated Herpesvirus Latent Origin , 2005, Journal of Virology.
[55] E. Knudsen,et al. The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Modulates Cellular Gene Expression and Protects Lymphoid Cells from p16 INK4A-induced Cell Cycle Arrest* , 2005, Journal of Biological Chemistry.
[56] Simon Kasif,et al. GC/AT-content spikes as genomic punctuation marks. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] William Stedman,et al. ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin , 2004, Journal of Virology.
[58] Shou-Jiang Gao,et al. Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence , 2004, Journal of Virology.
[59] S. Borah,et al. Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Up-Regulates Transcription of Human Telomerase Reverse Transcriptase Promoter through Interaction with Transcription Factor Sp1 , 2004, Journal of Virology.
[60] Yan Wang,et al. Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: cis-Acting Requirements for Replication and ori-Lyt-Associated RNA Transcription , 2004, Journal of Virology.
[61] C. Vinson,et al. Clustering of DNA sequences in human promoters. , 2004, Genome research.
[62] K. Yamanishi,et al. Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen , 2004, Journal of Virology.
[63] Joshua Orvis,et al. Regulation and Autoregulation of the Promoter for the Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus* , 2004, Journal of Biological Chemistry.
[64] B. Chandran,et al. Host Gene Induction and Transcriptional Reprogramming in Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8)-Infected Endothelial, Fibroblast, and B Cells , 2004, Cancer Research.
[65] J. Brady,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells , 2003, Journal of Virology.
[66] Yan Wang,et al. Kaposi's Sarcoma-Associated Herpesvirus Lytic Origin (ori-Lyt)-Dependent DNA Replication: Identification of the ori-Lyt and Association of K8 bZip Protein with the Origin , 2003, Journal of Virology.
[67] Frederick Y. Wu,et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus latency , 2003, Nature Medicine.
[68] Jianhong Hu,et al. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells , 2002, Journal of Virology.
[69] M. Fujimuro,et al. Protein Interactions Targeting the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus to Cell Chromosomes , 2002, Journal of Virology.
[70] Jianhong Hu,et al. Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.
[71] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[72] G. Hayward,et al. Altered Patterns of Cellular Gene Expression in Dermal Microvascular Endothelial Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus , 2002, Journal of Virology.
[73] Jianhong Hu,et al. DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[74] C. Lim,et al. The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus* , 2001, The Journal of Biological Chemistry.
[75] M. Ballestas,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA , 2001, Journal of Virology.
[76] A. Sharrocks,et al. Temporal Recruitment of the mSin3A-Histone Deacetylase Corepressor Complex to the ETS Domain Transcription Factor Elk-1 , 2001, Molecular and Cellular Biology.
[77] R. Hipskind,et al. Induction-independent Recruitment of CREB-binding Protein to the c-fos Serum Response Element through Interactions between the Bromodomain and Elk-1* , 2001, The Journal of Biological Chemistry.
[78] D. Dittmer,et al. Differential Regulation of the Overlapping Kaposi's Sarcoma-Associated Herpesvirus vGCR (orf74) and LANA (orf73) Promoters , 2001, Journal of Virology.
[79] P. Brown,et al. Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[80] C. Lim,et al. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. , 2000, The Journal of general virology.
[81] C. Boshoff,et al. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells , 2000, Nature Medicine.
[82] S. Mahajan,et al. Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies , 2000, Journal of Virology.
[83] G. Nabel,et al. p53 inhibition by the LANA protein of KSHV protects against cell death , 1999, Nature.
[84] E. Robertson,et al. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.
[85] M. Ballestas,et al. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.
[86] D. Ganem,et al. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. , 1997, The Journal of clinical investigation.
[87] L. Rainbow,et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.
[88] B. Dezube. Clinical presentation and natural history of AIDS--related Kaposi's sarcoma. , 1996, Hematology/oncology clinics of North America.
[89] J. Phair,et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.
[90] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[91] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[92] V. N. Roa,et al. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF , 1991, Nature.
[93] M. Rettig,et al. Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. , 2004, Blood.
[94] Terrence S. Furey,et al. The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..
[95] Michael Gribskov,et al. Combining evidence using p-values: application to sequence homology searches , 1998, Bioinform..
[96] Charles Elkan,et al. Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer , 1994, ISMB.